Three decades after the first Transcatheter Cardiovascular Therapeutics conference, TCT.18’s organizers are moving “toward a more practical approach,” says Cardiovascular Research Foundation CEO Juan Granada, MD.

French pharmaceutical company Servier has partnered with Bioserenity to launch a “smart T-shirt” they’re calling the Cardioskin—a wearable innovation that would allow heart patients to monitor their cardiac rhythm throughout the day, the Daily Mail has reported.

Minimally invasive cardiac surgery without peripheral cannulation is both safe and effective for correcting a wide range of congenital heart defects, including mitral valve repair and pulmonary stenosis, according to research published in Heart, Lung and Circulation this week.

A record seven states had adult obesity rates exceeding 35 percent in 2017, according to new data released by the CDC.

Certain characteristics predict how responsive a blood clot will be to intravenous alteplase, according to research published Sept. 11 in JAMA—knowledge that may help clinicians more efficiently triage patients with acute ischemic stroke.

Research out of Australia suggests newborns with congenital heart disease (CHD) are likely to have enlarged kidneys at birth—a finding that could help alert physicians to organ abnormalities before a child is born.

Scientists hope personalized data from patients experiencing irregular heartbeats will help improve accuracy in heart ablation procedures. The 3D simulations of 21 patients allow physicians to locate arrhythmia by “poking” the simulated heart with small electrical signals in various locations.

The Apple Watch Series 4—the device’s first major update since its introduction to the market three years ago—will feature an electrocardiogram in addition to its existing heart rate monitor, the Verge reported this week.